Eli Lilly and Co.Taltz1 x 80 mg/1 mL single-dose prefilled autoinjector per box
Indications and Usage
INDICATIONS AND USAGE
TALTZ ® is a humanized interleukin-17A antagonist indicated for the treatment of:
- patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
- adults with active psoriatic arthritis.
- adults with active ankylosing spondylitis.
- adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.
Plaque Psoriasis
TALTZ ® is indicated for the treatment of patients 6 years of age and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Psoriatic Arthritis
TALTZ is indicated for the treatment of adult patients with active psoriatic arthritis.
Ankylosing Spondylitis
TALTZ is indicated for the treatment of adult patients with active ankylosing spondylitis.
Non-radiographic Axial Spondyloarthritis
TALTZ is indicated for the treatment of adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation.
FAQsAll you need to know to order samples
Due to manufacturer restrictions, there are some limitations on the quantities of samples that can be included in each order. We're working on new functionality to let your practice place larger, batch orders.